[1]
Eneama, W.A., Salman, H.H. and Mousa , M.N. 2023. Isoxazolidine Derivatives Exhibit Selective Antitumor Activity Against Breast Cancer Cells. Academia Open. 9, 2 (Oct. 2023), 10.21070/acopen.9.2024.8148. DOI:https://doi.org/10.21070/acopen.9.2024.8148.